Larry Couture

Larry Couture

Amministratore Delegato presso
Orbsen Therapeutics Ltd.
69 anni
Health Technology
Consumer Services
Health Services

Profilo

Larry A. Couture currently works at Orbsen Therapeutics Ltd., as Chief Executive Officer & Director from 2016, City of Hope National Cancer Institute, as Senior Vice President & Founding Director from 1998, Westwood Bioscience, Inc., as Chief Operating Officer & Director from 2017, Multiverse Investments LLC, as Managing Member of General Partner from 2018, Vault Nano, Inc., as Secretary, and Fortem Neurosciences, Inc., as Secretary.
Dr. Couture also formerly worked at Arrogene, Inc., as Director in 2016, Genzyme Corp., as Principal, and National Institutes of Health, as Principal.
Dr. Couture received his undergraduate degree in 1976 from United States Air Force Academy, doctorate degree in 1989 from Albany Medical College, undergraduate degree in 1985 from the University of Colorado Boulder, and undergraduate degree in 1985 from the University of Colorado Boulder.

Posizioni attive di Larry Couture

SocietàPosizioneInizio
Corporate Officer/Principal 01/04/1998
Amministratore Delegato 06/09/2016
Investitore di Private Equity 01/10/2018
Segretario Aziendale -
Direttore operativo 01/03/2017
Segretario Aziendale -

Precedenti posizioni note di Larry Couture

SocietàPosizioneFine
Corporate Officer/Principal -
Amministratore Delegato -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Larry Couture

Formazione di Larry Couture

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

86

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Health Technology

Consumer Services

Government

Health Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Services

  1. Mercati
  2. Insiders
  3. Larry Couture
40% di sconto: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA